New NHIS Proposals Suggest Charging Family Heads Shs15000 for Each Dependent

Families will contribute Shillings 15,000 to the insurance pool for each member of their household should the cabinet approve the proposed National Health Insurance Scheme bill,” revealed the Health Minister, Dr. Ruth Aceng. She also highlighted the history of failed attempts by the Health Ministry to establish the national health insurance scheme since 2004. In…

Launching a Fresh Manifesto to Advocate for Increased Approval of HIV Prevention Choices Worldwide

HIV activists have expressed their dismay at the sluggish adoption of newly approved HIV prevention methods, such as the dapivirine vaginal ring and the cabotegravir injection, in African countries,” remarked Winnie Byanyima, the UNAIDS Executive Director. She was speaking at a meeting in Kampala during the launch of a new manifesto aimed at advocating for…

Lango Region Achieves Remarkable 9% Growth in Viral Load Suppression Over Five-Year Period

The Lango sub-region has witnessed a significant increase in Viral Load Suppression (VLS) over the past five years,” stated recent reports. “The suppression rate has risen to 94 percent between 2018 and 2022, in contrast to the previous ten years when the sub-region struggled to surpass a viral load suppression rate of 85 percent.” The…

Integrating HIV and NCD Health Services Yields Promising Outcomes, Report Finds

The integration of health services for people living with HIV and noncommunicable diseases (NCDs) can significantly enhance health outcomes and generate substantial returns on investment, according to a new report titled Spending Wisely: Exploring the economic and societal benefits of integrating HIV/AIDS and NCDs service delivery . The report, launched by the NCD Alliance and RTI International…

Major Price Drop Announced for Bedaquiline, a Vital Drug in TB Treatment

In a significant development, the Stop TB Partnership’s Global Drug Facility (GDF) has declared substantial price reductions of up to 55% for bedaquiline, a crucial drug used in treating drug-resistant TB (DR-TB). The revised bedaquiline prices, obtained through an open and competitive tender, will be in effect until December 2024, benefiting the majority of low-…

Largest genetic study of epilepsy to date provides new insights on why epilepsy develops and potential treatments

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.  The research, published in Nature Genetics, greatly advances our knowledge of why epilepsy develops and…